FDA Approves First New Type Of Antidepressant In Decades

Credit: Newsy Studio
Published on March 6, 2019 - Duration: 01:09s

FDA Approves First New Type Of Antidepressant In Decades

The fast-acting drug is primarily for people who have taken at least two other antidepressants unsuccessfully.

Advertisement

FDA Approves First New Type Of Antidepressant In Decades

The FDA approved its  first new type of antidepressant  in decades.  The drug's called esketamine — also known by the brand name Spravato — and it's a chemical cousin of ketamine, an anesthetic used in the club drug Special K.

It's a nasal spray used primarily for people who have taken at least two other antidepressants unsuccessfully.  The drug's manufacturer  Janssen Pharmaceuticals Inc.

 — which is owned by Johnson & Johnson — says it's most effective when taken with another oral antidepressant.

But one big improvement here is that it's fast-acting.

Many people don't see full benefits of some other antidepressants for weeks or months.  A director at the FDA said there'd been a "long-standing" need for this type of treatment.

An estimated one-third of people who suffer from major depressive disorder weren't benefiting from prior treatments.  The drug will have to be administered at an approved health care provider's office and cannot be taken home.

The patient will then be monitored for at least two hours, and common side effects include dizziness, nausea and feeling drunk.

You are here

Recent related videos from verified sources

FDA proposal would change mammogram regulations for first time in decades, what they'll mean for you 02:19
Credit: WXYZ Detroit - Published on April 1, 2019 

You might like